Your current location:Home > News > Industry News

The DeepSeek concept is hot, and domestic medical companies have announced their partnership with it


Time:2025-02-11 09:26:15  Source:  Author:

 

Recently, the DeepSeek concept has become popular, driving the AI application sector to soar. As of the close on February 10th, Huada Zhizao, Sichuang Yihui, Chuangye Huikang, Seri Medical, and Berry Gene have hit the daily limit up, while Wanda Information, Hongbo Pharmaceutical, and others have followed suit. In terms of Hong Kong stocks, Yidu Technology rose by over 25%, Minimally Invasive Robotics rose by over 21%, and companies such as Yimaitong and Zhiyun Health followed suit.

 
 
 
On the news front, several domestic medical companies have announced their partnership with DeepSeek to explore the application of models in multiple scenarios, which has attracted high market attention.
 
 
 
On February 10th, Jiahe Meikang announced on the interactive platform that the company has integrated with DeepSeek and is currently undergoing training in professional fields. In the future, the company will upgrade its existing medical AI applications (clinical decision-making assistance, medical record quality control, intelligent triage, medical record generation, etc.) based on the DeepSeek model, and will also explore new applications for clinical specialty application scenarios (emergency rescue scenarios, critical care management scenarios, etc.).
 
 
 
On February 8th, Fangzhou Jianke, a large online chronic disease management service platform in China, announced that it has successfully integrated with DeepSeek's open-source big model and completed localized deployment, marking an important upgrade in the company's technical architecture. The company stated that by deeply integrating DeepSeek's technological advantages, it will be able to better understand the needs of different users such as doctors and patients. This technological innovation not only improves the operational efficiency of the platform, but also brings users a better service experience.
 
 
 
On February 7th, Wanda Information announced on its investor interaction platform that the company has completed the localization deployment and computing power integration of the open-source version of DeepSeek in Wanda Information's own intelligent computing environment. Currently, DeepSeek is being integrated into the company's digital intelligent agent, large model service support platform, and other products to adapt to Wanda Information's industry models. The company is actively promoting its application in electronic medical records, clinical research, health management, e-government, smart communities, medical insurance, and other industry scenarios.
 
 
 
On the same day, Yingtong Technology, the first domestic enterprise to obtain the NMPA approved registration certificate for Class III artificial intelligence assisted diagnosis, announced that its independently developed Wanyu Medical Large Model has been upgraded and integrated with the DeepSeek R1 model. It is reported that the company laid out the Eagle Eye Wanyu Medical Big Model in July 2024 and upgraded to the DeepSeek R1 Big Model in February 2025, aiming to greatly improve clinical diagnosis efficiency and accuracy, provide more professional report interpretation and personalized patient health management experience.
 
 
 
On February 6th, Yidu Technology announced that it has integrated the DeepSeek artificial intelligence model into its independently developed "AI Medical Brain" YiduCore, which will further promote the large-scale application and innovative practice of AI technology in the healthcare industry. On the same day, Zhiyun Health announced that it will integrate the DeepSeeker R1 model into its exclusive medical artificial intelligence Zhiyun Brain, further enhancing the data mining capabilities of Zhiyun Brain and improving the chronic disease management efficiency of the company's hospital SaaS and pharmacy SaaS.
 
 
 
On February 6th, Hengrui Pharmaceutical announced internally that a special working group will be established to promote the application of AI tool Deepseek and include it in the assessment of cadres at all levels. It is reported that this decision is to actively adapt to the new trend of artificial intelligence development, promote the application of AI technology in business scenarios, and further improve work efficiency and management level.
 
 
 
In addition, Neusoft Medical, a leading domestic medical equipment company, is actively embracing the trend of new generation artificial intelligence technology, deeply integrating DeepSeek's algorithm with its own medical imaging technology, further improving the intelligence level of imaging equipment and the efficiency of imaging diagnosis work. For example, DeepSeek's multimodal data understanding and integration capabilities can help doctors provide multi-dimensional diagnostic reference information and generate detailed imaging analysis reports.

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL:+86-21-33585366(DDT)、34666753 FAX:+86-21-34979012
E-mail:info@shyrchem.com ADD:1885 Metropolitan Road, Minhang District, Shanghai Code:201108